168 related articles for article (PubMed ID: 30452719)
21. Benefit of Adjuvant Chemotherapy for Patients Older Than 75 Years With Completely Resected p-Stage II-IIIA Non-Small-Cell Lung Cancer: A Retrospective Cohort Study Using Japanese Nationwide Real-World Data.
Adachi H; Morohoshi T; Shintani Y; Okami J; Ito H; Ohtsuka T; Mori T; Watanabe SI; Chida M; Endo S; Nakanishi R; Kadokura M; Suzuki H; Miyaoka E; Yoshino I; Date H;
Clin Lung Cancer; 2024 Jan; 25(1):61-71.e1. PubMed ID: 37914595
[TBL] [Abstract][Full Text] [Related]
22. [Recent Status of Postoperative Adjuvant Chemotherapy after Completely Resected Lung Cancer].
Naito M; Tsuboi M
Gan To Kagaku Ryoho; 2016 Feb; 43(2):165-9. PubMed ID: 27067681
[TBL] [Abstract][Full Text] [Related]
23. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
24. [Lung cancer].
Nakagawa K; Kondo H
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1412-5. PubMed ID: 21918337
[TBL] [Abstract][Full Text] [Related]
25. Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
Soh J; Toyooka S; Okumura N; Nakamura H; Nakata M; Yamashita M; Sakamoto J; Aoe M; Hotta K; Morita S; Date H
Int J Clin Oncol; 2019 Nov; 24(11):1367-1376. PubMed ID: 31312931
[TBL] [Abstract][Full Text] [Related]
26. A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer.
Okamoto T; Yano T; Shimokawa M; Takeo S; Yamazaki K; Sugio K; Takenoyama M; Nagashima A; Tsukamoto S; Hamatake M; Yokoyama H; Ueda H; Motohiro A; Tagawa T; Shoji F; Kometani T; Saito G; Fukuyama Y; Toyokawa G; Osoegawa A; Emi Y; Maehara Y;
Lung Cancer; 2018 Oct; 124():255-259. PubMed ID: 30268470
[TBL] [Abstract][Full Text] [Related]
27. Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201.
Yamamoto H; Soh J; Okumura N; Suzuki H; Nakata M; Fujiwara T; Gemba K; Sano I; Fujinaga T; Kataoka M; Terazaki Y; Fujimoto N; Kataoka K; Kosaka S; Yamashita M; Inokawa H; Inoue M; Nakamura H; Yamashita Y; Hotta K; Yoshioka H; Morita S; Matsuo K; Sakamoto J; Date H; Toyooka S
PLoS One; 2023; 18(5):e0285273. PubMed ID: 37205678
[TBL] [Abstract][Full Text] [Related]
28. The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer.
Tsuboi M; Ohira T; Saji H; Miyajima K; Kajiwara N; Uchida O; Usuda J; Kato H
Ann Thorac Cardiovasc Surg; 2007 Apr; 13(2):73-7. PubMed ID: 17505412
[TBL] [Abstract][Full Text] [Related]
29. Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy.
Nishikubo M; Tanaka Y; Mitsui S; Doi T; Hokka D; Hojo W; Sakai H; Funakoshi Y; Yakushijin K; Ohji G; Minami H; Maniwa Y
Surg Today; 2023 Sep; 53(9):1057-1063. PubMed ID: 36752867
[TBL] [Abstract][Full Text] [Related]
30. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer.
Kassam F; Shepherd FA; Johnston M; Visbal A; Feld R; Darling G; Keshavjee S; Pierre A; Waddell T; Leighl NB
J Thorac Oncol; 2007 Jan; 2(1):39-43. PubMed ID: 17410008
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
[TBL] [Abstract][Full Text] [Related]
32. Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials.
Hamada C; Tsuboi M; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Thorac Oncol; 2009 Dec; 4(12):1511-6. PubMed ID: 19875974
[TBL] [Abstract][Full Text] [Related]
33. A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer.
Tanaka H; Tabe C; Okumura F; Shiratori T; Ishioka Y; Itoga M; Taima K; Morimoto T; Kimura D; Tsushima T; Tasaka S
Thorac Cancer; 2020 Jun; 11(6):1633-1638. PubMed ID: 32351044
[TBL] [Abstract][Full Text] [Related]
34. A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Oki E; Murata A; Yoshida K; Maeda K; Ikejiri K; Munemoto Y; Sasaki K; Matsuda C; Kotake M; Suenaga T; Matsuda H; Emi Y; Kakeji Y; Baba H; Hamada C; Saji S; Maehara Y
Ann Oncol; 2016 Jul; 27(7):1266-72. PubMed ID: 27056996
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study). The Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
Eur J Surg Oncol; 1995 Feb; 21(1):69-77. PubMed ID: 7851558
[TBL] [Abstract][Full Text] [Related]
36. A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected non-small cell lung cancer.
Ueda H; Sakada T; Kuwahara M; Motohiro A
Anticancer Drugs; 2004 Jan; 15(1):29-33. PubMed ID: 15090740
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Felip E; Altorki N; Zhou C; Csőszi T; Vynnychenko I; Goloborodko O; Luft A; Akopov A; Martinez-Marti A; Kenmotsu H; Chen YM; Chella A; Sugawara S; Voong D; Wu F; Yi J; Deng Y; McCleland M; Bennett E; Gitlitz B; Wakelee H;
Lancet; 2021 Oct; 398(10308):1344-1357. PubMed ID: 34555333
[TBL] [Abstract][Full Text] [Related]
38. Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: a prospective multi-institutional study in Japan.
Eguchi K; Oyama T; Tajima A; Abiko T; Sawafuji M; Horio H; Hashizume T; Matsutani N; Kato R; Nakayama M; Kawamura M; Kobayashi K
Lung Cancer; 2015 Jan; 87(1):53-8. PubMed ID: 25468199
[TBL] [Abstract][Full Text] [Related]
39. Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701.
Soh J; Okumura N; Nakata M; Nakamura H; Fukuda M; Kataoka M; Kajiwara S; Sano Y; Aoe M; Kataoka K; Hotta K; Matsuo K; Toyooka S; Date H
Jpn J Clin Oncol; 2016 Aug; 46(8):741-7. PubMed ID: 27207886
[TBL] [Abstract][Full Text] [Related]
40. Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
Wada H; Tanaka F; Hitomi S
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):98-102. PubMed ID: 9348578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
